“New Immunological Markers of Thromboembolic and Hemorrhagic Complications After Coronary Artery Bypass Grafting”. Asian Journal of Pharmaceutics (AJP), vol. 11, no. 04, Dec. 2017, https://doi.org/10.22377/ajp.v11i04.1734.